Table 2

The schedule of the screening period, perioperative period and evaluation period for this trial

ItemsScreening period (−7 to 0 days)Perioperative period of radical prostatectomy (1 to 14 days)Evaluation period
Demographic data
Signs and symptoms
Completed the blood test* and mpMRI examination
Evaluation by the online dynamic nomogram
Signing of informed consent forms
18F-PSMA-1007 PET/CT examination †
Enrolment
Radical prostatectomy §
Reading of pathological slices
Adverse events
  • *Prostate cancer marker test (serum PSA).

  • †The researchers decide whether an 18F-PSMA-1007 PET/CT examination is needed based on the results of the online nomogram evaluation.

  • §The researchers decide whether the radical prostatectomy is needed based on the decisions of the patients and their relatives.

  • 18F-PSMA-1007 PET/CT, 18F-prostate-specific membrane antigen-1007 positron emission tomography/CT; mpMRI, multiparameter MRI; PSA, prostate-specific antigen.